STOCK TITAN

BioSig Technologies Inc Stock Price, News & Analysis

BSGM Nasdaq

Welcome to our dedicated page for BioSig Technologies news (Ticker: BSGM), a resource for investors and traders seeking the latest updates and insights on BioSig Technologies stock.

BioSig Technologies Inc. (NASDAQ: BSGM) provides cutting-edge solutions in cardiac electrophysiology through its flagship PURE EP™ System. This page serves as the definitive source for official company news, including financial results, regulatory milestones, and clinical advancements.

Investors and healthcare professionals will find curated updates on product innovations, partnership announcements, and peer-reviewed research validating BioSig's signal processing technology. Key coverage areas: quarterly earnings reports, FDA clearances, hospital adoption metrics, and intellectual property developments.

All content undergoes strict verification to ensure alignment with SEC disclosure standards and medical device reporting regulations. Bookmark this page for real-time updates on BSGM's progress in enhancing cardiac ablation accuracy through advanced signal visualization technology.

Rhea-AI Summary

BioSig Technologies (NASDAQ: BSGM), recently merged with Streamex Exchange Corporation, has completed a $15 million public offering of common stock. The company sold 3,852,149 shares at $3.90 per share, with no pre-funded warrants included in the structure.

The offering, managed jointly by Clear Street and Needham & Company, was conducted under an effective S-3 shelf registration. The net proceeds will be primarily used to purchase gold bullion in accordance with the company's investment policy, along with general corporate purposes and working capital needs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.26%
Tags
-
Rhea-AI Summary

BioSig Technologies (NASDAQ: BSGM) has announced the pricing of its public offering of 3,852,149 shares of common stock at $3.90 per share. The offering, expected to close around August 15, 2025, aims to raise gross proceeds of approximately $15.02 million.

The company plans to use the net proceeds to purchase gold bullion according to its investment policy, along with working capital and general corporate purposes. Clear Street and Needham & Company are serving as joint book-running managers for this offering, which is being conducted under an effective S-3 shelf registration.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.5%
Tags
-
Rhea-AI Summary

BioSig Technologies (NASDAQ: BSGM), following its merger with Streamex Exchange Corporation, has announced plans for an underwritten public offering of common stock and pre-funded warrants. The company intends to use the proceeds to purchase gold bullion, working capital, and general corporate purposes.

Clear Street and Needham & Company will serve as joint book-running managers for the offering, which will be conducted under an effective S-3 shelf registration. The final size, timing, and terms of the offering remain subject to market conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.5%
Tags
Rhea-AI Summary

BioSig Technologies (NASDAQ: BSGM), following its merger with Streamex Exchange Corporation, has engaged Compliance Exchange Group (CXG) to acquire a FINRA and SEC registered broker-dealer. This strategic move positions Streamex to become one of the first Nasdaq-listed companies offering regulated Real-World Asset (RWA) tokenization services.

The acquisition aims to tap into the $22 trillion global gold market within the $142 trillion commodities sector. The company's Solana-based blockchain platform will enable efficient issuance and trading of gold-backed tokens, making gold investment more accessible to both institutional and retail investors. Streamex plans to hold significant vaulted gold quantities by 2026, denominating its balance sheet in physical gold to support a recurring revenue model.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.4%
Tags
-
Rhea-AI Summary

BioSig Technologies (NASDAQ: BSGM) has announced the appointment of Russell Starr as Strategic Advisor to Streamex following their recent merger. Starr, a former Bay Street executive and ex-CEO of DeFi Technologies, brings significant expertise in capital markets and decentralized finance. During his tenure at DeFi Technologies, he led the company to achieve over $200M USD in yearly revenue and grew the share price from $0.07 USD to $4.95 USD.

Starr joins Streamex's distinguished Advisory Board, which includes notable figures such as Frank Giustra (founder of Wheaton Precious Metals), Sean Roosen (founder of Osisko Development Corp), and other industry leaders. The appointment aligns with Streamex's mission to advance tokenized commodities and blockchain infrastructure development.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.75%
Tags
crypto
-
Rhea-AI Summary

BioSig Technologies (NASDAQ: BSGM) has announced the appointment of Russell Starr as Strategic Advisor to Streamex, following the company's recent merger with Streamex Exchange Corporation. Starr, formerly Head of Capital Markets Consultant at DeFi Technologies, brings extensive experience in capital markets, business development, and transformative deal-making.

The appointment strengthens Streamex's already impressive Advisory Board, which includes notable industry leaders such as Frank Giustra, founder of Wheaton Precious Metals ($37B) and GoldCorp, Sean Roosen of Osisko Development Corp, and other strategic advisors specializing in various aspects of capital markets, DeFi, and tokenized assets.

This strategic move aims to enhance Streamex's position in the tokenized asset space, combining Starr's expertise in decentralized finance with the company's focus on bringing commodities on chain.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.75%
Tags
crypto
Rhea-AI Summary

BioSig Technologies (NASDAQ: BSGM) has issued a correction to their July 11, 2025 press release regarding Russell Starr's appointment as Strategic Advisor to Streamex. The correction clarifies that during his time at DeFi Technologies, Starr served as Head of Capital Markets Consultant, not as CEO as previously implied.

The company corrected statements about Starr's role in DeFi Technologies' growth from $0.07 to $4.95 per share and achieving over $200M in yearly revenue. While at DeFi Technologies, Starr contributed to the company's strategic focus on Web3 infrastructure and helped facilitate its Nasdaq listing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.75%
Tags
none
-
Rhea-AI Summary

BioSig Technologies (NASDAQ:BSGM) has secured up to $1.1 billion in growth financing through definitive agreements with institutional investors. The financing includes $100 million in senior secured convertible debentures and a $1 billion equity line of credit over 36 months.

The company, which recently merged with Streamex Exchange Corporation, aims to become one of Nasdaq's largest public holders of gold bullion and plans to tokenize the $142 trillion commodities market using Streamex's real-world asset (RWA) platform powered by Solana blockchain. The debentures have a 24-month maturity with 4% annual interest, convertible into common stock.

The transaction, expected to close around October 7, 2025, was led by Cantor Fitzgerald & Co., Clear Street LLC, and Needham & Company as placement agents, with CIBC World Markets acting as Strategic Advisor.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-27.36%
Tags
none
-
Rhea-AI Summary
BioSig Technologies (NASDAQ: BSGM) has appointed Parcl co-founders Trevor Bacon and Kellan Grenier as Strategic Advisors following its acquisition of Streamex Exchange Corporation in May 2025. Parcl, a blockchain platform built on Solana, enables synthetic real estate trading without physical property ownership. Bacon, Parcl's CEO, brings over a decade of finance experience from Barclays and hedge funds, while Grenier, the COO, contributes expertise in blockchain and TMT sector analysis. They join BioSig's distinguished advisory board, which includes industry veterans Frank Giustra (founder of Wheaton Precious Metals and GoldCorp), Sean Roosen (founder of Osisko Development), and Mathew August (Executive Chairman of Atlas Capital Partners). The appointments aim to strengthen BioSig's capabilities in tokenizing and trading real-world assets, particularly in illiquid and fragmented markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.05%
Tags
none
Rhea-AI Summary
BioSig Technologies (NASDAQ: BSGM) has appointed Sean Roosen as Strategic Advisor to its recently acquired subsidiary Streamex Exchange Corporation. Roosen, a renowned mining entrepreneur, brings over 30 years of industry experience as the Founder and Executive Chairman/CEO of Osisko Development Corp and former leader of Osisko Gold Royalties. His notable achievements include developing the Canadian Malartic mine and being named Best CEO in North America by Mines and Money Americas in 2017. Roosen joins Streamex's distinguished advisory board alongside Frank Giustra, founder of Wheaton Precious Metals and GoldCorp, and Mathew August from Atlas Capital Partners. The appointment aims to accelerate Streamex's growth in the tokenized commodities space.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.59%
Tags
none

FAQ

What is the current stock price of BioSig Technologies (BSGM)?

The current stock price of BioSig Technologies (BSGM) is $4.72 as of August 20, 2025.

What is the market cap of BioSig Technologies (BSGM)?

The market cap of BioSig Technologies (BSGM) is approximately 172.2M.
BioSig Technologies Inc

Nasdaq:BSGM

BSGM Rankings

BSGM Stock Data

172.17M
21.24M
28.73%
28.66%
4.3%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
WESTPORT